| |
| |
|
| Insider
Information: |
Goddard Paul |
| Relationship: |
Chairman & CEO, Director |
| City: |
Exton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
338,988 |
|
|
Indirect Shares
|
95,702 |
|
|
| Direct
Value |
$498,065 |
|
|
|
Indirect Value
|
$26,100 |
|
|
| Total
Shares |
434,690 |
|
|
| Total
Value |
$524,165 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Onyx Pharmaceuticals Inc |
ONXX |
Director |
2013-10-01 |
0 |
2003-11-14 |
0 |
Premium* |
|
|
Xenoport Inc |
XNPT |
Director |
2005-06-07 |
50,831 |
|
0 |
Premium* |
|
|
Adolor Corp |
ADLR |
Director |
2010-05-18 |
5,141 |
2010-05-18 |
27,265 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
Director |
2010-05-20 |
214,683 |
2010-05-20 |
11,250 |
Premium* |
|
|
Aryx Therapeutics Inc |
ARYX |
Chairman & CEO, Director |
2007-11-13 |
68,333 |
2007-11-13 |
57,187 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-10-01 |
4 |
D |
$125.00 |
$262,500 |
D/D |
(2,100) |
0 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-10-01 |
4 |
D |
$125.00 |
$1,598,750 |
D/D |
(12,790) |
2,100 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-07-01 |
4 |
AS |
$131.92 |
$793,278 |
D/D |
(6,000) |
14,890 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-07-01 |
4 |
OE |
$12.50 |
$138,640 |
D/D |
6,000 |
20,890 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-05-08 |
4 |
AS |
$95.00 |
$95,000 |
D/D |
(1,000) |
14,890 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-05-08 |
4 |
OE |
$28.41 |
$28,410 |
D/D |
1,000 |
15,890 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-05-01 |
4 |
OE |
$12.50 |
$78,410 |
D/D |
5,000 |
19,890 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-05-01 |
4 |
AS |
$92.67 |
$465,087 |
D/D |
(5,000) |
14,890 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-04-10 |
4 |
AS |
$95.00 |
$190,000 |
D/D |
(2,000) |
14,890 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-04-10 |
4 |
OE |
$28.41 |
$56,820 |
D/D |
2,000 |
16,890 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,100 |
14,890 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-08 |
4 |
AS |
$85.00 |
$85,000 |
D/D |
(1,000) |
12,790 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-08 |
4 |
OE |
$28.41 |
$28,410 |
D/D |
1,000 |
13,790 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-01 |
4 |
OE |
$12.50 |
$50,000 |
D/D |
4,000 |
16,790 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-03-01 |
4 |
AS |
$74.35 |
$297,400 |
D/D |
(4,000) |
12,790 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-01-09 |
4 |
AS |
$82.75 |
$416,000 |
D/D |
(5,000) |
12,790 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2013-01-09 |
4 |
OE |
$33.56 |
$167,800 |
D/D |
5,000 |
17,790 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2012-08-30 |
4 |
S |
$71.40 |
$357,000 |
D/D |
(5,000) |
12,790 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2012-08-30 |
4 |
OE |
$4.78 |
$23,900 |
D/D |
5,000 |
17,790 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2012-07-25 |
4 |
A |
$0.00 |
$0 |
D/D |
1,500 |
12,790 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2012-03-30 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
11,290 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2011-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
8,290 |
0 |
- |
|
| ONXX |
Onyx Pharmaceuticals Inc |
Director |
– • – |
2010-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
5,290 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Director |
– • – |
2010-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
95,891 |
214,683 |
0 |
- |
|
| ADLR |
Adolor Corp |
Director |
– • – |
2010-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,958 |
5,141 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
